Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

E.M. Horwitz(St. Jude Children's Research Hospital), Katarina Le Blanc(Karolinska Institutet), Massimo Dominici(University of Modena and Reggio Emilia), Ingo Mueller(University Children's Hospital Tübingen), Ineke Slaper‐Cortenbach(University Medical Center Utrecht), F C Marini(The University of Texas MD Anderson Cancer Center), R. Deans(Athersys (United States)), D.S. Krause(Yale University), Armand Keating(Princess Margaret Cancer Centre)

Cytotherapy

January 1, 2005

10.1080/14653240500319234

Cited by 2,046

Abstract

Related Papers

Mesenchymal stem cells

Arnold I. Caplan|Journal of Orthopaedic Research®|1991|6.5k

Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues.

A. J. Friedenstein, K. V. Petrakova, Alexandra Ivanovna Kurolesova et al.|PubMed|1968|1.9k

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

Edwin M. Horwitz, Darwin J. Prockop, Lorraine A. Fitzpatrick et al.|Nature Medicine|1999|1.8k

HETEROTOPIC TRANSPLANTS OF BONE MARROW

A. J. Friedenstein, K. V. Petrakova, ALEXANDRA IVANOVNA KUROLESOVA et al.|Transplantation|1968|1.7k

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

Edwin M. Horwitz, Patricia Gordon, Winston K. K. Koo et al.|Proceedings of the National Academy of Sciences|2002|1.6k